The effect of Qinggan Yipi capsules on the gut microbiota in rats with liver fibrosis
Qinggan Yipi capsule (QgYp) has been widely used in clinical practice for its beneficial effects on liver protection. However, the mechanism of its treatment for hepatic fibrosis is not yet clear. We observed that Qinggan Yipi Capsule can improve the imbalance of gut microbiota. These findings are of significant importance for the treatment of hepatic fibrosis and provide potential contributions to the existing research on the mechanisms of hepatic fibrosis and the discovery of drugs for hepatic fibrosis.